Slowing life expectancy improvements linked to increase in deaths from dementia

July 18, 2017, Alzheimer's Research UK

A new report has highlighted increasing pressures on England's health services as deaths from dementia rise, coupled with a slowing in life expectancy increases.

The Marmot Indicators Briefing, published by the UCL Institute of Health Equity, is published on Tuesday 18 July and updates on several key measures that are used to track progress on policies aimed at reducing health inequalities.

The shows that although expectancy at birth is still rising across England, the rate of increase has slowed since 2010. Current estimates show that a one-year increase in life expectancy is now seen every 10 years for women and every six years for men – compared to every five years and every three and a half years respectively in 2010. At the same time, increases in remaining for people reaching the age of 65 have also slowed.

The report argues that deaths in old age have been driving this trend, with the number of deaths from on the rise as the number of older people has also increased. According to the analysis, deaths where dementia was a factor rose by 175% in women over 85 between 2002 and 2015, and 250% for men – partly due to the increase in diagnosis rates for dementia, and partly due to the increased numbers of people reaching old age.

Dr Matthew Norton, Director of Policy at Alzheimer's Research UK, said:

"This report shines a spotlight on a hard truth: that unless we can find ways to prevent and treat dementia, deaths from the condition will continue to rise as our population ages. Recent improvements in dementia diagnosis rates and changes to records account for some of this rise, but our ageing population is also a major factor. Dementia can affect a person's ability to manage a range of other in later life and therefore addressing dementia should be a major public health priority.

"Research into Alzheimer's and other dementias is progressing at pace, with more energies than ever before focused on translating our growing knowledge into benefits for patients. However, the reality today is that with no treatments to stop or slow the underlying diseases, the condition is placing an ever-growing strain on our . We cannot alleviate these pressures without new treatments and preventions, yet funding for dementia research is still playing catch-up, with just one dementia researcher for every four cancer scientists in the UK. Dementia is our greatest medical challenge, and this report is a reminder that we must redouble our efforts to fight this devastating condition."

Explore further: Deaths from Alzheimer's disease in Scotland increase by 31% in one year

Related Stories

Deaths from Alzheimer's disease in Scotland increase by 31% in one year

June 15, 2017
Deaths from dementia in Scotland have soared by 31 percent in a year, according to new statistics released by the National Records of Scotland today.

Recorded deaths from dementia more than double in 13 years

September 30, 2016
New figures released today show the proportion of people dying with a diagnosis of dementia more than doubled in 13 years. According to reports published by Public Health England, 15.8% of all deaths recorded in 2014 had ...

New figures show dementia is leading cause of death in England and Wales

November 14, 2016
New figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death for England and Wales. Of the 529,655 deaths registered during ...

Over 1.2 million people in England and Wales will be living with dementia by 2040

July 5, 2017
By 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), largely due to increased life expectancy, say researchers in The BMJ today.

Dementia is leading cause of death for women in England and Wales

November 10, 2015
New figures released by the Office for National Statistics have shown that Alzheimer's disease and other dementias were the leading cause of death for women in England and Wales in 2014, and the second leading cause of death ...

Report highlights increase in Alzheimer's drug prescriptions

January 20, 2016
A new report released today shows that Alzheimer's drug prescriptions have increased six times in the last decade, the proportion of people receiving a dementia diagnosis has increased over the last year by 112 per 100,000, ...

Recommended for you

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

July 17, 2018
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic ...

New study highlights Alzheimer's herpes link, experts say

July 12, 2018
A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018
Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

The 'Big Bang' of Alzheimer's: Scientists ID genesis of disease, focus efforts on shape-shifting tau

July 10, 2018
Scientists have discovered a "Big Bang" of Alzheimer's disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.

'Skinny fat' in older adults may predict dementia, Alzheimer's risk

July 5, 2018
A new study has found that "skinny fat—the combination of low muscle mass and strength in the context of high fat mass—may be an important predictor of cognitive performance in older adults. While sarcopenia, the loss ...

Pathway of Alzheimer's degeneration discovered

July 5, 2018
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer's disease, uncovering a pathway through which degeneration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.